Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170297 · ClinicalTrials.gov registry record
SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery
A clinical trial, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- 15
- Enrollment target
NCT03170297 is a clinical trial that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 15 participants.
The verdict
NCT03170297 has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to pilot data for a systematic molecular characterization of pathophysiologic perturbations incurred by snake envenomation and compare this to other inflammatory physiologic states such as trauma and sepsis. This sub-study will analyze samples of participants enrolled under the parent study "Surgical Critical Care Initiative Tissue and Data Acquisition Protocol".
Interventions
- OTHER Research interventions of blood sampling and data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-05-05 |
| Est. Completion | 2019-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170297
The ClinicalTrials.gov registry entry for NCT03170297 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Research interventions of blood sampling and data collection is the first listed.
NCT03170297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03170297 about?
NCT03170297 is a clinical study titled "SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery". The purpose of this study is to pilot data for a systematic molecular characterization of pathophysiologic perturbations incurred by snake envenomation and compare this to other inflammatory physiologic states such as trauma and sepsis. This sub-study will analyze samples of participants enrolled un...
What is the current status of trial NCT03170297?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2017-05-05. Estimated completion is 2019-12-15.
What interventions are being tested in trial NCT03170297?
The interventions under investigation include: Research interventions of blood sampling and data collection (OTHER).
Who is sponsoring clinical trial NCT03170297?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.